1Spatial provides a suite of software solutions and services that help organizations manage KPG Capital & CoMay 15, 2025
Octagon Therapeutics’ mission is to discover and develop better medicines for patients KPG Capital & CoMay 14, 2025
Obsidian’s mission is to develop and commercialize controllable cell and gene therapies KPG Capital & CoMay 14, 2025
NuvOx Pharma’s mission is to develop and commercialize novel therapeutics that improve oxygen KPG Capital & CoMay 14, 2025
Nurix’s mission is to develop innovative therapies that improve patient outcomes by harnessing the power KPG Capital & CoMay 14, 2025
Noxopharm, headquartered in Australia, operates with a mission to revolutionize the treatment landscape KPG Capital & CoMay 14, 2025
Novoron Bioscience focuses on developing therapies that promote regeneration and repair within the CNS KPG Capital & CoMay 14, 2025
Novadiscovery’s mission is to transform the drug development land− scape KPG Capital & CoMay 14, 2025
Novadip is a company specializing in regenerative medicine, focusing on developing advanced therapies KPG Capital & CoMay 14, 2025
Northway Biotech’s mission is to deliver top−tier development and manufacturing services KPG Capital & CoMay 14, 2025
Norstella is an industry leader dedicated to advancing the life sciences sector KPG Capital & CoMay 14, 2025
Norgine’s mission is to develop and deliver high quality pharmaceutical products KPG Capital & CoMay 14, 2025
Nordic Bioscience’s mission is to transform chronic disease research through the application KPG Capital & CoMay 14, 2025
Nkarta’s mission is to unlock the full potential of NK cells for cancer treatment, translating their natural tumor KPG Capital & CoMay 14, 2025
The NIDDK’s mission is to enhance the quality of life for individuals with chronic KPG Capital & CoMay 14, 2025
NGM’s mission is to harness the power of complex biology with rigor and urgency KPG Capital & CoMay 14, 2025
NG Biotech’s mission is to revolutionize the field of diagnostics by developing innovative KPG Capital & CoMay 14, 2025
